GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Dividend Payout Ratio

Sumitomo Pharma Co (Sumitomo Pharma Co) Dividend Payout Ratio : 0.00 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Dividend Payout Ratio?

Sumitomo Pharma Co's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Sumitomo Pharma Co's Dividend Payout Ratio or its related term are showing as below:


During the past 13 years, the highest Dividend Payout Ratio of Sumitomo Pharma Co was 1.00. The lowest was 0.13. And the median was 0.23.

DNPUF's Dividend Payout Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.33
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-04-29), the Dividend Yield % of Sumitomo Pharma Co is 1.80%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Sumitomo Pharma Co was 4.47%. The lowest was 0.47%. And the median was 1.38%.

Sumitomo Pharma Co's Dividends per Share for the months ended in Dec. 2023 was $0.00.

During the past 12 months, Sumitomo Pharma Co's average Dividends Per Share Growth Rate was -75.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -9.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 2.20% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 4.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sumitomo Pharma Co was 53.30% per year. The lowest was -9.10% per year. And the median was 15.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Sumitomo Pharma Co Dividend Payout Ratio Historical Data

The historical data trend for Sumitomo Pharma Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Dividend Payout Ratio Chart

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.27 0.20 0.20 -

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sumitomo Pharma Co's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sumitomo Pharma Co's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Dividend Payout Ratio falls into.


Sumitomo Pharma Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Sumitomo Pharma Co's Dividend Payout Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2023 )/ EPS without NRI (A: Mar. 2023 )
=0.157/ -1.403
=N/A

Sumitomo Pharma Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ -0.874
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co (OTCPK:DNPUF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Sumitomo Pharma Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Dividend Payout Ratio
Comparable Companies
TSE:4540 TSE:4887 TSE:4547 TSE:4521 TSE:4534 TSE:4553 TSE:4569 TSE:4551 TSE:4559 TSE:4886 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
4506:Japan DPM:Germany
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
https://www.sumitomo-pharma.com
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.